AEON Biopharma, Inc. (AEON)
0.1603
0.00 (0.00%)
USD |
NYAM |
Nov 06, 10:21
AEON Biopharma Net Income (Quarterly) : -1.155M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.155M |
| March 31, 2026 | -11.79M |
| December 31, 2025 | -37.14M |
| September 30, 2025 | -4.538M |
| June 30, 2025 | -6.642M |
| March 31, 2025 | 9.095M |
| December 31, 2024 | 2.082M |
| September 30, 2024 | -6.171M |
| June 30, 2024 | 164.11M |
| March 31, 2024 | -118.02M |
| December 31, 2023 | -26.24M |
| September 30, 2023 | -325.37M |
| Date | Value |
|---|---|
| June 30, 2023 | -15.38M |
| March 31, 2023 | -17.64M |
| December 31, 2022 | -34.56M |
| September 30, 2022 | -10.44M |
| June 30, 2022 | 1.867M |
| March 31, 2022 | 2.773M |
| December 31, 2021 | 0.2479M |
| September 30, 2021 | 5.659M |
| June 30, 2021 | -4.025M |
| March 31, 2021 | 6.319M |
| December 31, 2020 | -0.0036M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 53.52M |
| Alnylam Pharmaceuticals, Inc. | 2.167B |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 1.155M |
| EPS Diluted (Quarterly) | -0.0229 |
| Enterprise Value | 3.503M |
| Earnings Yield | -2.35K% |
| Normalized Earnings Yield | -1623.96 |